288 related articles for article (PubMed ID: 19351365)
1. Comparative expression of syndecan-1 and Ki-67 in peripheral and desmoplastic ameloblastomas and ameloblastic carcinoma.
Bologna-Molina R; Mosqueda-Taylor A; Lopez-Corella E; de Almeida OP; Carrasco-Daza D; Farfán-Morales JE; Molina-Frechero N; Damián-Matsumura P
Pathol Int; 2009 Apr; 59(4):229-33. PubMed ID: 19351365
[TBL] [Abstract][Full Text] [Related]
2. Syndecan-1 (CD138) and Ki-67 expression in different subtypes of ameloblastomas.
Bologna-Molina R; Mosqueda-Taylor A; Lopez-Corella E; Almeida OP; Carrasco-Daza D; Garcia-Vazquez F; Farfan-Morales JE; Irigoyen-Camacho ME; Damián-Matsumura P
Oral Oncol; 2008 Aug; 44(8):805-11. PubMed ID: 18207448
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection of insulin-like growth factors, platelet-derived growth factor, and their receptors in ameloblastic tumors.
Kumamoto H; Ooya K
J Oral Pathol Med; 2007 Apr; 36(4):198-206. PubMed ID: 17391297
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of K6, K8, K16, K17, K19, maspin, syndecan-1 (CD138), α-SMA, and Ki-67 in ameloblastoma and ameloblastic carcinoma: diagnostic and prognostic correlations.
Safadi RA; Quda BF; Hammad HM
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Apr; 121(4):402-11. PubMed ID: 26972539
[TBL] [Abstract][Full Text] [Related]
5. [Expression of Ki-67 antigen in ameloblastoma and its clinical significance].
Han B; Li L; Wang H
Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Apr; 21(2):153-4. PubMed ID: 12838707
[TBL] [Abstract][Full Text] [Related]
6. Is podoplanin expression associated with the proliferative activity of ameloblastomas?
Tjioe KC; Oliveira DT; Soares CT; Lauris JR; Damante JH
Oral Dis; 2012 Oct; 18(7):673-9. PubMed ID: 22443371
[TBL] [Abstract][Full Text] [Related]
7. A immunohistochemical study of the peripheral ameloblastoma.
Kishino M; Murakami S; Yuki M; Iida S; Ogawa Y; Kogo M; Toyosawa S
Oral Dis; 2007 Nov; 13(6):575-80. PubMed ID: 17944675
[TBL] [Abstract][Full Text] [Related]
8. Comparative immunohistochemical study of ameloblastoma and ameloblastic carcinoma.
Yoon HJ; Jo BC; Shin WJ; Cho YA; Lee JI; Hong SP; Hong SD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Dec; 112(6):767-76. PubMed ID: 22014999
[TBL] [Abstract][Full Text] [Related]
9. Comparative expression of RANK, RANKL, and OPG in keratocystic odontogenic tumors, ameloblastomas, and dentigerous cysts.
da Silva TA; Batista AC; Mendonça EF; Leles CR; Fukada S; Cunha FQ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Mar; 105(3):333-41. PubMed ID: 18061491
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of MDM2 protein in ameloblastomas as compared to adenomatoid odontogenic tumor.
Krishna A; Kaveri H; Naveen Kumar RK; Kumaraswamy KL; Shylaja S; Murthy S
J Cancer Res Ther; 2012; 8(2):232-7. PubMed ID: 22842367
[TBL] [Abstract][Full Text] [Related]
11. Ki-67 expression in dentigerous cysts, unicystic ameloblastomas, and ameloblastomas arising from dental cysts.
Piattelli A; Lezzi G; Fioroni M; Santinelli A; Rubini C
J Endod; 2002 Feb; 28(2):55-8. PubMed ID: 11833688
[TBL] [Abstract][Full Text] [Related]
12. Proliferating cell nuclear antigen and Ki67 immunoreactivity in ameloblastomas.
Meer S; Galpin JS; Altini M; Coleman H; Ali H
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Feb; 95(2):213-21. PubMed ID: 12582363
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical investigation of epidermal growth factor receptor expression in ameloblastomas.
Ueno S; Miyagawa T; Kaji R; Mushimoto K; Shirasu R
J Pathol; 1994 May; 173(1):33-8. PubMed ID: 7931835
[TBL] [Abstract][Full Text] [Related]
14. Ameloblastoma and adenomatoid odontogenic tumor: the role of alpha2beta1, alpha3beta1, and alpha5beta1 integrins in local invasiveness and architectural characteristics.
Souza Andrade ES; da Costa Miguel MC; Pinto LP; de Souza LB
Ann Diagn Pathol; 2007 Jun; 11(3):199-205. PubMed ID: 17498594
[TBL] [Abstract][Full Text] [Related]
15. Syndecan-1 and syndecan-4 are overexpressed in an estrogen receptor-negative, highly proliferative breast carcinoma subtype.
Baba F; Swartz K; van Buren R; Eickhoff J; Zhang Y; Wolberg W; Friedl A
Breast Cancer Res Treat; 2006 Jul; 98(1):91-8. PubMed ID: 16636895
[TBL] [Abstract][Full Text] [Related]
16. CD10 expression in stromal cells of ameloblastoma variants.
Iezzi G; Piattelli A; Rubini C; Artese L; Goteri G; Fioroni M; Carinci F
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Feb; 105(2):206-9. PubMed ID: 17942343
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical detection of phosphorylated JNK, p38 MAPK, and ERK5 in ameloblastic tumors.
Kumamoto H; Ooya K
J Oral Pathol Med; 2007 Oct; 36(9):543-9. PubMed ID: 17850438
[TBL] [Abstract][Full Text] [Related]
18. Comparative expression of calretinin in selected odontogenic tumours: a possible relationship to histogenesis.
Alaeddini M; Etemad-Moghadam S; Baghaii F
Histopathology; 2008 Feb; 52(3):299-304. PubMed ID: 18269580
[TBL] [Abstract][Full Text] [Related]
19. DNA ploidy of ameloblastoma and ameloblastic carcinoma of the jaws. Analysis by image and flow cytometry.
Müller S; DeRose PB; Cohen C
Arch Pathol Lab Med; 1993 Nov; 117(11):1126-31. PubMed ID: 8239934
[TBL] [Abstract][Full Text] [Related]
20. Differences in E-Cadherin and Syndecan-1 Expression in Different Types of Ameloblastomas.
Carreón-Burciaga RG; González-González R; Molina-Frechero N; López-Verdín S; Pereira-Prado V; Bologna-Molina R
Anal Cell Pathol (Amst); 2018; 2018():9392632. PubMed ID: 29850393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
